human isogenic cell lines

NEW YORK (GenomeWeb News) – Horizon Discovery announced today a research service agreement to deploy its X-MAN isogenic cell lines in support of Blueprint Medicine's "New Targets" discovery platform.

NEW YORK (GenomeWeb News) – Horizon Discovery said today it has entered into a research collaboration covering gene editing with the Institute of Neurology, University College London.

NEW YORK (GenomeWeb News) – Crown Bioscience and Horizon Discovery today announced that they will partner on offering new in vivo X-MAN models as a service to Crown's customers.

NEW YORK (GenomeWeb News) – Horizon Discovery today said that it has established a Center of Excellence at Washington University in St. Louis.

NEW YORK (GenomeWeb News) – Horizon Discover today said it has signed a licensing and distribution deal with the American Type Culture Collection for certain sets of panels of X-Man isogenic cell lines.

NEW YORK (GenomeWeb News) – Horizon Discovery today announced it has signed an agreement with Bayer Pharma for the use of Horizon's Genesis genome editing technology in support of Bayer's cancer R&D programs.

NEW YORK (GenomeWeb News) – Horizon Discovery and biopharmaceutical firm H3 Biomedicine today announced a collaboration to identify and validate a panel of novel cancer drug targets.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Horizon Discover today said it is collaborating with the Rosalind Franklin University of Medical Sciences to develop a human cellular disease model of cystic fibrosis.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Horizon Discovery today announced a collaboration with Promega to develop next-generation predictive human disease models.

Pages

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.